NovoCure (NVCR) Interest Coverage Ratio (QoQ) (2014 - 2022)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -1,910.71% |
| Mar 31, 2022 | 95.62% |
| Dec 31, 2021 | -149.19% |
| Sep 30, 2021 | 66.99% |
| Jun 30, 2021 | -39,228.54% |
| Mar 31, 2021 | -100.90% |
| Dec 31, 2020 | -1.86% |
| Sep 30, 2020 | 48.02% |
| Jun 30, 2020 | 283.28% |
| Mar 31, 2020 | -1,685.57% |
| Dec 31, 2019 | -94.19% |
| Sep 30, 2019 | 56.31% |
| Jun 30, 2019 | 137.41% |
| Mar 31, 2019 | 35.67% |
| Dec 31, 2018 | -83.28% |
| Sep 30, 2018 | 11.65% |
| Jun 30, 2018 | 5.17% |
| Mar 31, 2018 | -38.20% |
| Dec 31, 2017 | 31.15% |
| Sep 30, 2017 | 61.41% |
| Jun 30, 2017 | -30.12% |
| Mar 31, 2017 | -23.10% |
| Dec 31, 2016 | 65.60% |
| Sep 30, 2016 | 80.75% |
| Jun 30, 2016 | -15.33% |
| Mar 31, 2016 | -66.13% |
| Dec 31, 2015 | -16.88% |
| Sep 30, 2015 | 3.53% |
| Jun 30, 2015 | 16.36% |
| Mar 31, 2015 | 68.37% |
| Dec 31, 2014 | 65.25% |